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Dhatever we may have observed, perceived, or believed over
he course of many years of our clinical practice and
athology research pertaining to atherosclerotic coronary
isease, we have paid undivided attention to the luminal
tenosis. The characteristics of the vascular wall have not
eceived enough attention. Although the demonstration of
uminal obstruction or consequent reduction in blood flow
ay explain symptomatic status of coronary disease, it does
ot accurately determine the likelihood of acute coronary
vents. Luminal interrogation does not offer detection of
ulnerable plaques.
We have inherited, imbibed, and communicated not-so-
ccurate notions about vulnerable plaques. We have tacitly
elieved that even trivial plaques may rupture and that the
rterial tree may have such plaques in abundance. Such a
otion is primarily based on the fact that the culprit lesions
esulting in acute coronary events often have not shown
ignificant angiographic luminal obstruction. However,
athological studies have demonstrated that lesions likely to
e vulnerable to rupture usually are not multiple, occur more
ften in the proximal and middle part of major arteries and,
n a large proportion of cases, are fairly sizable. These
esions involve at least 50% of cross-sectional vascular area
n more than 80% of instances, and the necrotic cores often
ccupy 60° of vessel circumferentially and 10% to 25% of
laque area. Such lesions longitudinally span as long as up to
cm and assume vulnerability wherever the necrotic cores
urface. The vulnerable sites are not necessarily confined to
laque shoulders. Such lesions may only display minimal
ncroachment on the lumen because of positive remodeling.
he vulnerable lesions often occur in proximal or middle
arts of coronary arteries. Relative proximity of these sizable
esions renders them amenable to imaging modalities.
The detection of vulnerable atherosclerotic plaques will
e dependent upon demonstration of thin fibrous caps and
arge necrotic cores. Such techniques may involve noninva-
ive imaging by computed tomography or magnetic reso-
ance imaging in the future. Invasive techniques could
nvolve intravascular ultrasound, optical coherence, and
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Manuscript received June 16, 2005; accepted June 27, 2005.ntravascular magnetic resonance imaging, or near-infrared
nd thermographic measurements. Only optical coherence
omography may allow evaluation of fibrous cap thickness.
The necrotic cores are perpetuated by intraplaque hem-
rrhages, which often are secondary to exaggerated plaque
eovascularization. Vascularization and intraplaque hemor-
hage may provide additional targets for imaging. An
xidized lipid state is associated with plaque and systemic
nflammation. Whereas 18F-deoxyglucose positron emission
omographic imaging could become a noninvasive indicator
f plaque inflammation, C-reactive protein and other
iomarkers will continue to allow the detection of a systemic
nflammatory state.
Although the recognition of systemic inflammation de-
cribes the patients at high risk of developing acute events
vulnerable patients), imaging modalities will need to iden-
ify the lesions at imminent risk of inducing events (vulner-
ble plaques). With a unique objective of stimulating
iscussion targeted at development of imaging techniques,
mersham Healthcare (now GE Healthcare) organized a
Vulnerable Plaque Symposium” in Boston in October
003. Widely acclaimed investigators from all over the
orld participated in the symposium. All participants con-
ributed to this supplement supported by GE Healthcare
nd Astellas Healthcare. The emphasis of this volume is on
dentification of vulnerable plaques. The consensus reaffirms
hat we need the attention of cardiologists, who should
qually be committed to evaluating the arterial lumen and
he plaques themselves, especially in noncritically obstructed
rteries.
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